Applications of blood group antigen expression systems for antibody detection and identification

Transfusion

Volumn 47, Issue SUPPL. 1, 2007, Pages

  Yazdanbakhsh, Karina ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; RECOMBINANT ANTIGEN;

ALLELE; ANTIBODY DETECTION; ANTIGEN EXPRESSION; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; GENETIC IDENTIFICATION; HUMAN; IMMUNOASSAY; IMMUNOGENETICS; MOLECULAR GENETICS;

ADSORPTION; ANTIBODIES; ANTIGENS, SURFACE; BLOOD GROUP ANTIGENS; CLONING, MOLECULAR; GENE EXPRESSION; HUMANS; IMMUNOLOGIC TECHNIQUES; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS;

EID: 34250673910     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01317.x     Document Type: Conference Paper

References (19)

1. Logdberg L, Reid ME, Lamont RE, et al. Human blood group genes 2004: chromosomal locations and cloning strategies. Transfus Med Rev 2005 19 : 45 57.
2. Westhoff CM. Molecular testing for transfusion medicine. Curr Opin Hematol 2006 13 : 471 5.
3. Kornfeld S. Diseases of abnormal protein glycosylation: an emerging area. J Clin Invest 1998 101 : 1293 5.
4. Jackson JA. Baculovirus expression systems and insect cells. Bioprocess Technol 1991 13 : 402 13.
5. Suyama K, Lunn R, Haller S, et al. Rh (D) antigen expression and isolation of a new Rh (D) cDNA isoform in human erythroleukemic K562 cells. Blood 1994 84 : 1975 81.
6. Chu T-HT, Yazdanbakhsh K, Øyen R, et al. Production and characterization of anti-Kell monoclonal antibodies using transfected cells as the immunogen. Br J Haematol 1999 106 : 817 23.
7. Friend C, Scher W, Holland JG, et al. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A 1971 68 : 378 82.
8. van Assendelft G, Hanscombe O, Grosveld F, et al. The b-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner. Cell 1989 56 : 969 77.
9. Talbot D, Collis P, Antoniou M, et al. A dominant control region from the human beta-globin locus conferring integration site-independent gene expression. Nature 1989 338 : 352 5.
10. Yazdanbakhsh K, Øyen R, Yu Q, et al. High level, stable expression of blood group antigens in a heterologous system. Am J Hematol 2000 63 : 114 24.
11. Yazdanbakhsh K, Lee S, Yu Q, et al. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999 94 : 310 8.
12. Yazdanbakhsh K, Rios M, Storry JR, et al. Molecular mechanisms that lead to reduced expression of Duffy antigens. Transfusion 2000 40 : 310 20.
13. Van Kim CL, Colin Y, Cartron JP. Rh proteins: key structural and functional components of the red cell membrane. Blood Rev 2006 20 : 93 110.
14. Vengelen-Tyler V. Technical manual, 13th edition. Bethesda, MD : American Association of Blood Banks, 1999.
15. Moulds JM, Rowe KE. Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion 1996 36 : 517 20.
16. Daniels GL, Green CA, Powell RM, et al. Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor. Transfusion 1998 38 : 332 6.
17. Petty AC, Daniels GL, Tippett P. Application of the MAIEA assay to the Kell blood group system. Vox Sang 1994 66 : 216 24.
18. Telen MJ, Rao N, Udani M, et al. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994 84 : 3205 11.
19. Tamasauskas D, Powell V, Schawalder A, et al. Localization of Knops system antigens in the long homologous repeats (LHRs) of complement receptor 1. Transfusion 2001 41 : 1397 404.